Basit öğe kaydını göster

Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus

dc.contributor.authorGordon, Caroline
dc.contributor.authorDooley, Mary Anne
dc.contributor.authorEnocsson, Helena
dc.contributor.authorWirestam, Lina
dc.contributor.authorDahle, Charlotte
dc.contributor.authorPadyukov, Leonid
dc.contributor.authorJonsen, Andreas
dc.contributor.authorUrowitz, Murray B.
dc.contributor.authorGladmane, Dafna D.
dc.contributor.authorROMERO-DIAZ, Juanita
dc.contributor.authorBAE, Sang-Cheol
dc.contributor.authorKALUNIAN, Kenneth C.
dc.contributor.authorVAN VOLLENHOVEN, Ronald F.
dc.contributor.authorRAMOS-CASALS, Manuel
dc.contributor.authorKAMEN, Diane L.
dc.contributor.authorJACOBSEN, Soren
dc.contributor.authorPeschken, Christine A.
dc.contributor.authorAskanase, Anca
dc.contributor.authorSTOLL, Thomas
dc.contributor.authorBruce, Ian N.
dc.contributor.authorWettero, Jonas
dc.contributor.authorSjowall, Christopher
dc.contributor.authorInanc, Murat
dc.contributor.authorMANZI, Susan
dc.contributor.authorRamsey-Goldman, Rosalind
dc.contributor.authorNived, Ola
dc.contributor.authorSTEINSSON, Kristjan
dc.contributor.authorZOMA, Asad A.
dc.contributor.authorRUIZ-IRASTORZA, Guillermo
dc.contributor.authorLim, S. Sam
dc.contributor.authorFortin, Paul R.
dc.contributor.authorSanchez-Guerrero, Jorge
dc.contributor.authorClarke, Ann E.
dc.contributor.authorBernatsky, Sasha
dc.contributor.authorHANLY, John G.
dc.contributor.authorWALLACE, Daniel J.
dc.contributor.authorIsenberg, David A.
dc.contributor.authorRahman, Anisur
dc.contributor.authorMERRILL, Joan T.
dc.contributor.authorGINZLER, Ellen
dc.contributor.authorALARCON, Graciela S.
dc.contributor.authorCHATHAM, W. Winn
dc.contributor.authorPetri, Michelle
dc.contributor.authorKHAMASHTA, Munther
dc.contributor.authorARANOW, Cynthia
dc.contributor.authorMACKAY, Meggan
dc.date.accessioned2021-03-03T15:20:01Z
dc.date.available2021-03-03T15:20:01Z
dc.identifier.citationEnocsson H., Wirestam L., Dahle C., Padyukov L., Jonsen A., Urowitz M. B. , Gladmane D. D. , ROMERO-DIAZ J., BAE S., Fortin P. R. , et al., "Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus", JOURNAL OF AUTOIMMUNITY, cilt.106, 2020
dc.identifier.issn0896-8411
dc.identifier.othervv_1032021
dc.identifier.otherav_3e774bce-94e9-4692-9003-20b3ed454865
dc.identifier.urihttp://hdl.handle.net/20.500.12627/45847
dc.identifier.urihttps://doi.org/10.1016/j.jaut.2019.102340
dc.description.abstractObjective: The soluble urokinase plasminogen activator receptor (suPAR) has potential as a prognosis and severity biomarker in several inflammatory and infectious diseases. In a previous cross-sectional study, suPAR levels were shown to reflect damage accrual in cases of systemic lupus erythematosus (SLE). Herein, we evaluated suPAR as a predictor of future organ damage in recent-onset SLE.
dc.language.isoeng
dc.subjectİmmünoloji
dc.subjectTemel Bilimler
dc.subjectYaşam Bilimleri
dc.subjectYaşam Bilimleri (LIFE)
dc.titleSoluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus
dc.typeMakale
dc.relation.journalJOURNAL OF AUTOIMMUNITY
dc.contributor.department, ,
dc.identifier.volume106
dc.contributor.firstauthorID35798


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster